Markers of low tPA activity consistently described in schizophrenia include hyperhomocysteinemia and antiphospholipid antibodies, such as lupus anticoagulant and IgM isotype anticardiolipin antibody [16,17,18]. This evidence concerns the gene PLAT and hyperhomocysteinemia.